A dopamine precursor
Related Products
Active Metabolite(s)
364433-Methoxytyrosine
Enantiomer(s)
13249D-DOPA
Isomer(s)
36382Forphenicinol
Labeled Version(s)
22089L-DOPA-d3
Metabolite(s)
207373-O-methyl-L-DOPA (hydrate)
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

L-DOPA

Item No. 13248

Technical Information
Formal Name
3-hydroxy-L-tyrosine
CAS Number
59-92-7
Synonyms
  • 3,4-Dihydroxyphenylalanine
  • Levodopa
Molecular Formula
C9H11NO4
Formula Weight
Purity
≥95%
A crystalline solid
SMILES
OC1=CC(C[C@H](N)C(O)=O)=CC=C1O
InChi Code
InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)
InChi Key
WTDRDQBEARUVNC-UHFFFAOYSA-N
Origin
Synthetic
Shipping & Storage Information
Storage
Room temperature
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    L-DOPA is a metabolic precursor of dopamine that is capable of crossing the blood-brain barrier.1 It is produced from L-tyrosine by tyrosine hydroxylase and metabolized by catechol-O-methyl transferase (COMT). In the brain L-DOPA is converted to dopamine. Formulations containing L-DOPA have been used in stroke recovery and in the treatment of Parkinson's disease.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Berends, H.I., Nijlant, J.M.M., Movig, K.L.L., et alThe clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review. Eur. J. Phys. Rehabil. Med. 45(4), 621-630 (2009).